Hacettepe University — Çankaya, Ankara

Public research footprint of Hacettepe University, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Scleroderma (Limited and Diffuse) · Systemic Sclerosis (SSc) · Scleroderma, Localized · Central Line Associated Blood Stream Infections (CLABSI)

Recently updated registry entries

NCT06822426 — Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream… (Recruiting)
NCT04544449 — A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in… (Active Not Recruiting)
NCT05611931 — Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hacettepe University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.